Orange Grove Bio
Cincinnati, US · Founded 2019 · Delaware LLC · 2 known investors
Orange Grove Bio is a drug investment and development firm that licenses biomedical innovation from universities and research institutions to create and build biotechnology companies developing therapies for cancer, autoimmune, and inflammatory diseases. It runs sourcing, diligence, and operations processes with partner scientists to advance pharmaceutical assets through clinical development.
BiotechDeep TechHealthtech
Founders & leadership
MA
Marc AppelNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 1 round · 2022
▶$16.6MraisedAug 2022 · 15 investors · Other Health CareRule 506(b)
▶$16.6MraisedAug 2022 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc AppelExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $16.6M
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Orange Grove Bio went on to found or lead other companies.
Competitors · 4
by search overlapMission BioCapital Platinum Program Holdings LLC39 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.
Related19 shared keywordsRelated Sciences assembles distributed teams of academic experts and industry veterans to conduct specialized drug discovery and research for biotech companies. The company operates a decentralized R&D model where leading scientists work collaboratively on targeted therapeutic programs.
Samsara Biocapital16 shared keywordsSamsara Capital is an investment firm that backs the development of therapeutics for patients. It brings together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.
bio16 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Companies competing with Orange Grove Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Orange Grove Bio do?
- Orange Grove Bio is a drug investment and development firm that licenses biomedical innovation from universities and research institutions to create and build biotechnology companies developing therapies for cancer, autoimmune, and inflammatory diseases. It runs sourcing, diligence, and operations processes with partner scientists to advance pharmaceutical assets through clinical development.
- Who are Orange Grove Bio's investors?
- Orange Grove Bio's investors include AlleyCorp, Alley Robotics Ventures.
- How much funding has Orange Grove Bio raised?
- Orange Grove Bio has disclosed $16.6M raised across 1 round.
- Where is Orange Grove Bio headquartered?
- Orange Grove Bio is headquartered in Cincinnati, US.